Zhiyun Peng - Search Results

Year	Number of Results
2011	1
2012	2
2013	4
2015	1
2016	6
2017	3
2018	3
2019	3
2020	8
2021	7
2022	14
2023	12
2024	1

1

An overview: metal-based inhibitors of urease.

Yang W, Peng Z, Wang G. Yang W, et al. Among authors: peng z. J Enzyme Inhib Med Chem. 2023 Dec;38(1):361-375. doi: 10.1080/14756366.2022.2150182. J Enzyme Inhib Med Chem. 2023. PMID: 36446640 Free PMC article. Review.

2

Occurrence, synthesis and biological activity of 2-(2-phenyethyl)chromones.

Fan M, Yang W, He M, Li Y, Peng Z, Wang G. Fan M, et al. Among authors: peng z. Eur J Med Chem. 2022 Jul 5;237:114397. doi: 10.1016/j.ejmech.2022.114397. Epub 2022 Apr 19. Eur J Med Chem. 2022. PMID: 35472851 Review.

3

7-Meth-oxy-3-(4-meth-oxy-phen-yl)chroman-4-one.

Peng ZY, Liu XY, Yang YL, Xiang KS, Xiao ZP. Peng ZY, et al. Acta Crystallogr Sect E Struct Rep Online. 2012 Feb 1;68(Pt 2):o250. doi: 10.1107/S1600536811055048. Epub 2012 Jan 7. Acta Crystallogr Sect E Struct Rep Online. 2012. PMID: 22346898 Free PMC article.

4

A review on synthetic chalcone derivatives as tubulin polymerisation inhibitors.

Liu W, He M, Li Y, Peng Z, Wang G. Liu W, et al. Among authors: peng z. J Enzyme Inhib Med Chem. 2022 Dec;37(1):9-38. doi: 10.1080/14756366.2021.1976772. J Enzyme Inhib Med Chem. 2022. PMID: 34894980 Free PMC article. Review.

5

Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy.

Feng Q, Yang W, Peng Z, Wang G. Feng Q, et al. Among authors: peng z. Eur J Pharmacol. 2022 Nov 5;934:175319. doi: 10.1016/j.ejphar.2022.175319. Epub 2022 Oct 8. Eur J Pharmacol. 2022. PMID: 36220359 Review.

6

An overview on the synthetic urease inhibitors with structure-activity relationship and molecular docking.

Yang W, Feng Q, Peng Z, Wang G. Yang W, et al. Among authors: peng z. Eur J Med Chem. 2022 Apr 15;234:114273. doi: 10.1016/j.ejmech.2022.114273. Epub 2022 Mar 12. Eur J Med Chem. 2022. PMID: 35305460 Review.

7

An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.

He M, Fan M, Peng Z, Wang G. He M, et al. Among authors: peng z. Eur J Med Chem. 2021 Oct 5;221:113546. doi: 10.1016/j.ejmech.2021.113546. Epub 2021 May 14. Eur J Med Chem. 2021. PMID: 34023737 Review.

8

Chromone-based benzohydrazide derivatives as potential α-glucosidase inhibitor: Synthesis, biological evaluation and molecular docking study.

Fan M, Yang W, Peng Z, He Y, Wang G. Fan M, et al. Among authors: peng z. Bioorg Chem. 2023 Feb;131:106276. doi: 10.1016/j.bioorg.2022.106276. Epub 2022 Nov 17. Bioorg Chem. 2023. PMID: 36434950

9

A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship.

Peng Z, Wang G, Zeng QH, Li Y, Liu H, Wang JJ, Zhao Y. Peng Z, et al. Crit Rev Food Sci Nutr. 2022;62(15):4053-4094. doi: 10.1080/10408398.2021.1871724. Epub 2021 Jan 18. Crit Rev Food Sci Nutr. 2022. PMID: 33459057

10

Synthesis and antitumor activity of litseaone B analogues as tubulin polymerisation inhibitors.

Yang W, Peng H, Huang Y, Peng Z, Wang G. Yang W, et al. Among authors: peng z. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2530-2539. doi: 10.1080/14756366.2022.2122962. J Enzyme Inhib Med Chem. 2022. PMID: 36100238 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

54 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year